A purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies.
Kristin Thomas
Advertisement
Kristin Thomas is senior scientist at Pfizer Global Research and Development Global Biologics, Bioprocess R&D
Articles by Kristin Thomas
A purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
FDA Accepts BLA for Formycon and Zydus’ FYB206, the First Publicly Announced Keytruda Biosimilar Under Review
2
FDA Rare Disease Framework Initiative: What It Means for Drug and Biologic Development
3
Gilead Taps Vir Biotechnology's PRO-XTEN Tech for Solid Tumors
4
BioNTech's BNT113 Misses PFS Goal in Head and Neck Cancer Trial
5